Corrie Berk, DNP, MBA

Loma Linda University Health, Las Vegas, NV

Disclosures:
Speakers Bureau: Gilead – HCV; Salix – HE
Carolyn Catalano, APN

Rutgers-RWJ Medical School, New Brunswick, NJ 

Disclosures:
No financial relationships to disclose.
Elisabeth R. Evans, MSN, FNP-BC

San Diego, CA

Disclosures:
Exact Sciences Corporation Employee July 2019 – Present
Sr. Medical Science Liaison and AOPH Scientific Specialist
Elizabeth K. Goacher, PA-C, MHS

Duke University Medical Center, Durham, NC

Disclosures:
Consultant: AbbVie, Clinical Area – Viral Hepatitis; Gilead, Clinical Area – Viral Hepatitis; Intercept, Clinical Area – PBC, NASH
Speakers Bureau: AbbVie, Clinical Area – Viral Hepatitis; Gilead, Clinical Area – Viral Hepatitis; Intercept, Clinical Area – PBC, NASH
Christina Hanson, FNP-C

South Denver Gastroenterology, Englewood, CO

Disclosures:
Consultant: Salix, Clinical Area – HE, IBS-D
Speakers Bureau: AbbVie, Clinical Area – HCV; Salix, Clinical Area – HE, IBS-D; Intercept, Clinical Area – PBC
Allison Hobbs, MSN, APRN, FNP-C

University of Louisville Hospital, Louisville KY

Disclosures:
No financial relationships to disclose.
Patrick M. Horne, MSN, APRN-FNP

University of Florida-UF Health, Gainesville, FL 

Disclosures:
Consultant: AbbVie, Clinical Area – Hepatitis C; Fuji-Film Wako, Clinical Area – HCC; Gilead, Clinical Area – Hepatitis B, Hepatitis C, NASH; Intercept, Clinical Area – PBC, NASH
Bridget Howard, NP

Mayo Clinic, Scottsdale, AZ 

Disclosures:
No financial relationships to disclose.
Nicole Martinez de Andino, RD, NP-C

Augusta University, Augusta, GA

Disclosures:
Steering Committee: Salix, Clinical Area – IBS-D, IBS-S, Hepatology
Jordan Mayberry, PA-C

UT Southwestern Medical Center, Dallas, TX

Disclosures:
Consultant: Intercept, Clinical Area: PBC, NASH
Gabriella McCarty, RN, MSN, NP-C

North Shore Gastroenterology, Westlake OH

Disclosures:
Speakers Bureau: AbbVie, Clinical Area – IBD; Allergan/Abbvie, Clinical Area – IBS-D, IBS-C, CIC;
Pfizer, Clinical Area – IBD; Salix, Clinical Area – IBS, HE; Janssen, Clinical Area – IBD
Ann Moore, FNP-C

Arizona Liver Health, Chandler, AZ 

Disclosures:
Consultant: AbbVie, Clinical Area – HCV; Gilead Clinical Area – HBV, HCV; Intercept, Clinical Area – NASH, PBC
April G. Morris, FNP

Hunter Holmes McGuire VA Medical Center, Richmond VA

Disclosures:
Speakers Bureau: AbbVie, Clinical Area – HCV; Gilead Sciences, Clinical Area – HCV; Intercept Pharmaceuticals,
Clinical Area – NASH
Consultant: AbbVie, Clinical Area – HCV; Intercept, Clinical Area – NASH
Monica Nandwani, DNP, RN, FNP-BC

Stanford Health Care, Redwood City CA 

Disclosures:
No financial relationships to disclose.
Gail Pearson, MSN, FNP-C

South Denver Gastroenterology, Englewood, CO

Disclosures:
Speakers Bureau: Salix, Clinical Area – IBS-D and HE
Renee Pozza, PhD, RN, FNP-BC

Southern California Liver Centers, Riverside CA

Disclosures:
No financial relationships to disclose.
Lisa Richards, FNP-BC

UC San Diego Health System, San Diego, CA 

Disclosures:
Speakers Bureau: Intercept Pharmaceutical, Clinical Area – NAFLD
Vicki Shah, PA-C, MMS

Rush University Chicago, IL

Disclosures:
Research Support: Gilead, Clinical Area – HCV
Consultant: AbbVie, Clinical Area – HCV
C. Shane Smith, PA-C

Gastroenterology Associates, Pensacola, FL

Disclosures:
Speakers Bureau: AbbVie, Clinical Area – Hepatitis C; Gilead, Clinical Area – Hepatitis C
K. Tuesday Werner, DNP, FNP-C

Mayo Clinic Arizona, Phoenix, AZ 

Disclosures:
Speakers Bureau: Salix, Clinical area – Hepatic Encephalopathy